Administration of thrombolytic therapy to 17,944 patients with acute myocardial infarction

The GISSI-3 database

M. Bobbio, S. Bergerone, A. P. Maggioni, R. Malacrida, M. G. Franzosi, S. Barlera, G. Tognoni

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: There is growing interest in assessing therapy for acute myocardial infarction. Because thrombolysis was not a study therapy in the GISSI-3 trial, the decision about thrombolysis was left to the responsible physicians. We evaluated the data on thrombolytic therapy among patients with acute myocardial infarction enrolled in the GISSI-3 trial to study the relation between rate of prescription and the characteristics of patients and participating coronary care units. Methods: Complete clinical data were available for 17,944 patients randomized between June 1991 and July 1993 from 200 coronary care units in Italy. Demographic and clinical information were obtained for each patient, and each coronary care unit was classified according to patient volume, level of technology, and wide geographic area in which it was located. A multivariate logistic regression was performed with administration of thrombolytic therapy as the dependent variable and previously defined clinical and structural variables as independent variables. Results: The most important factor in administration of thrombolytic therapy was that less than 6 hours elapse from symptom onset to hospital admission (odds ratio [OR] 14.05; 95% confidence interval [CI] 12.3 to 16.0). Next were location of coronary care unit in southern Italy (OR 1.81; 95% CI 1.62 to 2.01), presence of ST elevation at entrance electrocardiogram ECG (OR 1.47; 95% CI 1.35 to 1.61), absence of previous myocardial infarction (OR 1.35; 95% CI 1.22 to 1.49), and presence of catheterization laboratory or cardiac surgery program or both in the same hospital (OR 1.24; 95% CI 1.14 to 1.35). Coronary care units with high or low patient volume did not show different rates of administration of thrombolytic agents. Conclusions: The GISSI-3 experience confirmed a high rate of prescription of thrombolytic therapy to patients admitted within 6 hours of symptom onset and those with ST-segment elevation on entrance electrocardiogram. It demonstrated that patients admitted to coronary care units with catheterization laboratories or cardiac programs or both have higher chances of receiving thrombolytic treatment than those admitted to hospitals without these capabilities.

Original languageEnglish
Pages (from-to)443-448
Number of pages6
JournalAmerican Heart Journal
Volume135
Issue number3
DOIs
Publication statusPublished - 1998

Fingerprint

Thrombolytic Therapy
Coronary Care Units
Myocardial Infarction
Databases
Odds Ratio
Confidence Intervals
Electrocardiography
Catheterization
Italy
Prescriptions
Fibrinolytic Agents
Thoracic Surgery
Therapeutics
Logistic Models
Demography
Technology
Physicians

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Bobbio, M., Bergerone, S., Maggioni, A. P., Malacrida, R., Franzosi, M. G., Barlera, S., & Tognoni, G. (1998). Administration of thrombolytic therapy to 17,944 patients with acute myocardial infarction: The GISSI-3 database. American Heart Journal, 135(3), 443-448. https://doi.org/10.1016/S0002-8703(98)70320-5

Administration of thrombolytic therapy to 17,944 patients with acute myocardial infarction : The GISSI-3 database. / Bobbio, M.; Bergerone, S.; Maggioni, A. P.; Malacrida, R.; Franzosi, M. G.; Barlera, S.; Tognoni, G.

In: American Heart Journal, Vol. 135, No. 3, 1998, p. 443-448.

Research output: Contribution to journalArticle

Bobbio, M, Bergerone, S, Maggioni, AP, Malacrida, R, Franzosi, MG, Barlera, S & Tognoni, G 1998, 'Administration of thrombolytic therapy to 17,944 patients with acute myocardial infarction: The GISSI-3 database', American Heart Journal, vol. 135, no. 3, pp. 443-448. https://doi.org/10.1016/S0002-8703(98)70320-5
Bobbio, M. ; Bergerone, S. ; Maggioni, A. P. ; Malacrida, R. ; Franzosi, M. G. ; Barlera, S. ; Tognoni, G. / Administration of thrombolytic therapy to 17,944 patients with acute myocardial infarction : The GISSI-3 database. In: American Heart Journal. 1998 ; Vol. 135, No. 3. pp. 443-448.
@article{f3c1b6e667db4852afa7c8fabf785da2,
title = "Administration of thrombolytic therapy to 17,944 patients with acute myocardial infarction: The GISSI-3 database",
abstract = "Background: There is growing interest in assessing therapy for acute myocardial infarction. Because thrombolysis was not a study therapy in the GISSI-3 trial, the decision about thrombolysis was left to the responsible physicians. We evaluated the data on thrombolytic therapy among patients with acute myocardial infarction enrolled in the GISSI-3 trial to study the relation between rate of prescription and the characteristics of patients and participating coronary care units. Methods: Complete clinical data were available for 17,944 patients randomized between June 1991 and July 1993 from 200 coronary care units in Italy. Demographic and clinical information were obtained for each patient, and each coronary care unit was classified according to patient volume, level of technology, and wide geographic area in which it was located. A multivariate logistic regression was performed with administration of thrombolytic therapy as the dependent variable and previously defined clinical and structural variables as independent variables. Results: The most important factor in administration of thrombolytic therapy was that less than 6 hours elapse from symptom onset to hospital admission (odds ratio [OR] 14.05; 95{\%} confidence interval [CI] 12.3 to 16.0). Next were location of coronary care unit in southern Italy (OR 1.81; 95{\%} CI 1.62 to 2.01), presence of ST elevation at entrance electrocardiogram ECG (OR 1.47; 95{\%} CI 1.35 to 1.61), absence of previous myocardial infarction (OR 1.35; 95{\%} CI 1.22 to 1.49), and presence of catheterization laboratory or cardiac surgery program or both in the same hospital (OR 1.24; 95{\%} CI 1.14 to 1.35). Coronary care units with high or low patient volume did not show different rates of administration of thrombolytic agents. Conclusions: The GISSI-3 experience confirmed a high rate of prescription of thrombolytic therapy to patients admitted within 6 hours of symptom onset and those with ST-segment elevation on entrance electrocardiogram. It demonstrated that patients admitted to coronary care units with catheterization laboratories or cardiac programs or both have higher chances of receiving thrombolytic treatment than those admitted to hospitals without these capabilities.",
author = "M. Bobbio and S. Bergerone and Maggioni, {A. P.} and R. Malacrida and Franzosi, {M. G.} and S. Barlera and G. Tognoni",
year = "1998",
doi = "10.1016/S0002-8703(98)70320-5",
language = "English",
volume = "135",
pages = "443--448",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Administration of thrombolytic therapy to 17,944 patients with acute myocardial infarction

T2 - The GISSI-3 database

AU - Bobbio, M.

AU - Bergerone, S.

AU - Maggioni, A. P.

AU - Malacrida, R.

AU - Franzosi, M. G.

AU - Barlera, S.

AU - Tognoni, G.

PY - 1998

Y1 - 1998

N2 - Background: There is growing interest in assessing therapy for acute myocardial infarction. Because thrombolysis was not a study therapy in the GISSI-3 trial, the decision about thrombolysis was left to the responsible physicians. We evaluated the data on thrombolytic therapy among patients with acute myocardial infarction enrolled in the GISSI-3 trial to study the relation between rate of prescription and the characteristics of patients and participating coronary care units. Methods: Complete clinical data were available for 17,944 patients randomized between June 1991 and July 1993 from 200 coronary care units in Italy. Demographic and clinical information were obtained for each patient, and each coronary care unit was classified according to patient volume, level of technology, and wide geographic area in which it was located. A multivariate logistic regression was performed with administration of thrombolytic therapy as the dependent variable and previously defined clinical and structural variables as independent variables. Results: The most important factor in administration of thrombolytic therapy was that less than 6 hours elapse from symptom onset to hospital admission (odds ratio [OR] 14.05; 95% confidence interval [CI] 12.3 to 16.0). Next were location of coronary care unit in southern Italy (OR 1.81; 95% CI 1.62 to 2.01), presence of ST elevation at entrance electrocardiogram ECG (OR 1.47; 95% CI 1.35 to 1.61), absence of previous myocardial infarction (OR 1.35; 95% CI 1.22 to 1.49), and presence of catheterization laboratory or cardiac surgery program or both in the same hospital (OR 1.24; 95% CI 1.14 to 1.35). Coronary care units with high or low patient volume did not show different rates of administration of thrombolytic agents. Conclusions: The GISSI-3 experience confirmed a high rate of prescription of thrombolytic therapy to patients admitted within 6 hours of symptom onset and those with ST-segment elevation on entrance electrocardiogram. It demonstrated that patients admitted to coronary care units with catheterization laboratories or cardiac programs or both have higher chances of receiving thrombolytic treatment than those admitted to hospitals without these capabilities.

AB - Background: There is growing interest in assessing therapy for acute myocardial infarction. Because thrombolysis was not a study therapy in the GISSI-3 trial, the decision about thrombolysis was left to the responsible physicians. We evaluated the data on thrombolytic therapy among patients with acute myocardial infarction enrolled in the GISSI-3 trial to study the relation between rate of prescription and the characteristics of patients and participating coronary care units. Methods: Complete clinical data were available for 17,944 patients randomized between June 1991 and July 1993 from 200 coronary care units in Italy. Demographic and clinical information were obtained for each patient, and each coronary care unit was classified according to patient volume, level of technology, and wide geographic area in which it was located. A multivariate logistic regression was performed with administration of thrombolytic therapy as the dependent variable and previously defined clinical and structural variables as independent variables. Results: The most important factor in administration of thrombolytic therapy was that less than 6 hours elapse from symptom onset to hospital admission (odds ratio [OR] 14.05; 95% confidence interval [CI] 12.3 to 16.0). Next were location of coronary care unit in southern Italy (OR 1.81; 95% CI 1.62 to 2.01), presence of ST elevation at entrance electrocardiogram ECG (OR 1.47; 95% CI 1.35 to 1.61), absence of previous myocardial infarction (OR 1.35; 95% CI 1.22 to 1.49), and presence of catheterization laboratory or cardiac surgery program or both in the same hospital (OR 1.24; 95% CI 1.14 to 1.35). Coronary care units with high or low patient volume did not show different rates of administration of thrombolytic agents. Conclusions: The GISSI-3 experience confirmed a high rate of prescription of thrombolytic therapy to patients admitted within 6 hours of symptom onset and those with ST-segment elevation on entrance electrocardiogram. It demonstrated that patients admitted to coronary care units with catheterization laboratories or cardiac programs or both have higher chances of receiving thrombolytic treatment than those admitted to hospitals without these capabilities.

UR - http://www.scopus.com/inward/record.url?scp=0031917739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031917739&partnerID=8YFLogxK

U2 - 10.1016/S0002-8703(98)70320-5

DO - 10.1016/S0002-8703(98)70320-5

M3 - Article

VL - 135

SP - 443

EP - 448

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 3

ER -